Bringing together over 400 of the most influential biomanufacturing folks, BioProduction 2017 will provide you with the latest updates across all phases of biomanufacturing, practical tips for tackling regulatory challenges head on, and a detailed overview of industry innovations in mammalian and microbial production.
Bioproduction helps you overcome the major challenges faced in the manufacturing of biological therapies: primarily monoclonal antibodies (mAbs). Also this year get to grips with the production of novel non monoclonal antibody products, e.g. biosimilars, bispecific, antibody drug conjugates and fragments and gain an understanding of how microbial expression systems can help drive these products to market.
It looks at the latest strategies to optimise upstream and downstream processing, minimise costs and stress on internal resources, as well as the strategies used to ensure product quality, safety and yield in line with international regulations.
Key topics include increasing product yield, optimising process, reducing timelines, ensuring quality, overcoming late stage bottlenecks and developing novel therapies coming out of the R&D department.
BioProduction looks at all aspects of large scale, commercial/ GMP manufacturing including the latest technologies, facility design, single use systems, continuous manufacturing and strategies for reducing inefficiencies during the bio manufacturing process, rather than just looking at ways to optimise the process.
Price
Standart (industry) rate: GBP 1699
Vendor/Consulting/Supplier prices: GBP 1899
Academic rate: GBP 499
Speakers: Bayer, Boehringer Ingelheim, Merck, National Institute of Bioprocessing Research & Training (NIBRT), Regeneron Pharmaceuticals, Allergan Biologics, Takeda Vaccines, Bristol Myers Squibb, PM Group, Asahi Kasai
Bioproduction helps you overcome the major challenges faced in the manufacturing of biological therapies: primarily monoclonal antibodies (mAbs). Also this year get to grips with the production of novel non monoclonal antibody products, e.g. biosimilars, bispecific, antibody drug conjugates and fragments and gain an understanding of how microbial expression systems can help drive these products to market.
It looks at the latest strategies to optimise upstream and downstream processing, minimise costs and stress on internal resources, as well as the strategies used to ensure product quality, safety and yield in line with international regulations.
Key topics include increasing product yield, optimising process, reducing timelines, ensuring quality, overcoming late stage bottlenecks and developing novel therapies coming out of the R&D department.
BioProduction looks at all aspects of large scale, commercial/ GMP manufacturing including the latest technologies, facility design, single use systems, continuous manufacturing and strategies for reducing inefficiencies during the bio manufacturing process, rather than just looking at ways to optimise the process.
Price
Standart (industry) rate: GBP 1699
Vendor/Consulting/Supplier prices: GBP 1899
Academic rate: GBP 499
Speakers: Bayer, Boehringer Ingelheim, Merck, National Institute of Bioprocessing Research & Training (NIBRT), Regeneron Pharmaceuticals, Allergan Biologics, Takeda Vaccines, Bristol Myers Squibb, PM Group, Asahi Kasai
